Furthermore, we confirmed the role of IDH1 R132H mutations in affecting cellular redox status using glioma cell lines, and provided evidence to further explore the application of chemotherapy such as 5-FU in the treatment of gliomas with IDH1 R132H mutation. This evidence concerns the gene IDH1 and glioma.